Page 25 - AWA Vol.42-No.8 issue
P. 25

POULTRy


         Neion Bio brings Barnwell Bio's biosurveillance into its egg-

                                based drug manufacturing flocks
         Neion Bio, the New York company that
        engineers  hens to make  biologics  in
        their eggs, will partner with Barnwell Bio
        to use its avian biosurveillance technol-
        ogy. Barnwell will track the health  and
        microbial environment of Neion's flocks
        as Neion scales its Raptor manufacturing
        platform.
         The deal follows from how Neion makes
        drugs. Its platform programs hens to ex-
        press recombinant proteins, including
        monoclonal  antibodies, enzymes and
        fusion  proteins, directly in  egg whites.
        That swaps steel bioreactors for animals
        and turns flock health into a manufac-
        turing variable. In a conventional plant,
        contamination  is an event in a tank. In
        Neion's, it is an event in a barn.
         Neion argues the animal model also   "Monitoring COVID-19 in wastewater   of goods by up to 10 times and capital
        brings something steel does not.
                                            consistently produced valuable signal   spending by up to 100 times against con-
         "One of the  advantages  of  the Raptor   on  how the  virus was spreading weeks   ventional  manufacturing.  Those figures
        platform  is that it can create a level of   ahead of reported cases and hospitaliza-  have not been independently shown.
        redundancy in biologics manufacturing   tions. At Barnwell Bio, we often identify
        that is difficult to achieve with traditional   elevated pathogen load in the barn en-  The fit is simple on paper.
        bioprocessing.  We are not dependent   vironment ahead of clinical signs, giving   "Neion  uses chickens to manufacture
        on a single large bioreactor or manufac-  producers early visibility  into animal   recombinant proteins. Barnwell provides
        turing site. At the same time, the health   health and the data  they need to act,"   the intelligence needed to  understand
        of the flock remains critically important   said Michael Rhys, cofounder and CEO   and protect the health environment
        to the productivity and reliability of the   of Barnwell Bio.           in which those chickens live,"  Kellari
        system," said Dimi  Kellari, cofounder   Barnwell, in its January funding an-  added.
        and CEO of Neion  Bio in an exclusive   nouncement, put  the cost of bird flu to
        conversation with Synbiobeta.       the US  economy at  $14  billion across   Both  companies  are  based in  Manhat-
         Barnwell works at the level of the pop-  2024 and 2025. Barnwell raised a $6 mil-  tan, an unusual  address for chicken bi-
                                                                                ology, and a test of how far New York's
        ulation rather than the bird. Instead of   lion seed round in January led by Twelve
        testing individual  animals for named   Below. Poultry is its starting market, with   life sciences push reaches beyond ther-
        pathogens, it  sequences  environmental   swine, dairy and aquaculture named as   apeutics and diagnostics. That push has
        samples and, the company says, turns   extensions.                      lost some institutional  support. In June,
        hundreds of thousands of data  points   The timing tracks Neion's own scale-  Crain's New York Business reported that
        into a  microbiome fingerprint  for each   up.                          the city's economic development agency
        facility. Barnwell says that fingerprint                                had cut its life sciences workforce, rais-
        can flag a pathogen spike ahead of other   "As Neion moves from platform devel-  ing fears about  the industry's  growth.
        methods. "We have been able to find un-  opment toward larger-scale production,   The mayor's office did not respond to a
        usual pathogen loads in the environment   biosecurity and flock health become   request for comment on the partnership.
        weeks ahead of clinical signs," said Mi-  increasingly important. Barnwell al-  For operators, the question is whether
        chael Rhys, cofounder and CEO of Barn-  ready has a system  capable of provid-  an  animal-based  process can  offer the
        well Bio.                           ing actionable information in real-world
                                            poultry environments, so we are able to   control that partners and regulators ex-
         "Barnwell gives us a  way to continu-  incorporate that capability into our man-  pect of a bioreactor. A biologics process
        ously monitor  the health environment   ufacturing strategy now rather than hav-  is defined by what it measures. Neion
        around the birds, identify potential is-  ing to develop it ourselves," said Kellari.  says the first year is about building that
        sues early, and take action before they                                 record.
        affect flock performance," said Dimi Kel-  Neion, which  SynBioBeta profiled in
        lari, cofounder and CEO of Neion Bio.  April, emerged from stealth in March   "Over the next 12 months, our priority
                                            with a co-development  and supply   is to integrate that monitoring into our
         The approach comes straight from pan-  agreement  with an unnamed major   operations,  establish a  baseline under-
        demic surveillance.  Barnwell says  its   pharmaceutical company covering  up   standing of the flock  environment, and
        founding team helped build the national   to three monoclonal antibodies. It raised   use the resulting data to support biose-
        COVID-19 wastewater monitoring sys-  about $11 million in seed funding led by   curity, animal health, and ultimately man-
        tem, and its January seed release names   Caffeinated Capital, then a  $23 million   ufacturing performance," Kellari said.
        cofounder and COO Casey McGinley as   Series A in June, again led by Caffein-
        part of that effort.                ated. Neion says its approach can cut cost              Circle 28 on enquiry card
                                                                                                    Vol. 42 No. 8   23
   20   21   22   23   24   25   26   27   28   29   30